P-538 Sequential treatment with docetaxel-cisplatin (DP) doublet allows higher conversion to response for patients (pts) with advanced NSCLC in stable disease (SD) after 2 courses of gemcitabine-cisplatin (GP): Preliminary results of a pilot study
Moscetti, L., Nelli, F., Sperduti, I., Signorelli, C., Santiccioli, S., Saltarelli, R., Capomolla, E., Pollena, C.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81031-1
Date:
July, 2005
File:
PDF, 150 KB
english, 2005